Indications
Therapeutic Asset Ratings
18,135 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Diphenhydramine
Cervical Cancer
National Cancer Institute (NCI)
P3
BB
(67)
Diphenhydramine
Lung Cancer
Ciusss de L'Est de l'Île de Montréal
P3
BB
(67)
Docetaxel
Hormone Receptor-Positive Breast Cancer
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(67)
Docetaxel
Peritoneal Neoplasm
Clinica Universidad de Navarra, Universidad de Navarra
P3
BB
(67)
Dolutegravir
Amyotrophic Lateral Sclerosis
Macquarie University, Australia
P3
BB
(67)
Duvelisib
Follicular Lymphoma
Ruijin Hospital
P3
BB
(67)
Elacestrant
Breast Carcinoma
Kristina A. Fanucci
P3
BB
(67)
Elafibranor
Primary Sclerosing Cholangitis
Ipsen
P3
BB
(67)
Encukalner
Major Depressive Disorder
Xenon Pharmaceuticals Inc.
P3
BB
(67)
Entecavir
B-Cell Non-Hodgkin Lymphoma
Sun Yat-sen University
P3
BB
(67)
Eribulin Monomethanesulfonate
Invasive Breast Carcinoma
National Cancer Institute (NCI)
P3
BB
(67)
Eribulin Monomethanesulfonate
Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BB
(67)
Etodolac
Colorectal Neoplasm
Assaf-Harofeh Medical Center
P3
BB
(67)
Everolimus
HER2 Positive Breast Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(67)
Everolimus
Lymphangioleiomyomatosis
University of Cincinnati
P3
BB
(67)
FCH
Hepatocellular Carcinoma
Queen's Medical Center
P3
BB
(67)
FDOPA
Congenital Isolated Hyperinsulinism
University of Alberta
P3
BB
(67)
Fenebrutinib
Relapsing-Remitting Multiple Sclerosis
Hoffmann-La Roche
P3
BB
(67)
Fludarabine
Myeloid Neoplasm
First Affiliated Hospital of Zhejiang University
P3
BB
(67)
Fludrocortisone
Metastatic Prostate Carcinoma
Merck Sharp & Dohme LLC
P3
BB
(67)
Fludrocortisone
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLC
P3
BB
(67)
Fludrocortisone
Prostate Neoplasm
Merck Sharp & Dohme LLC
P3
BB
(67)
Gilteritinib
Acute Myeloid Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
P3
BB
(67)
Gilteritinib
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
The First Affiliated Hospital of Soochow University
P3
BB
(67)
hs-10241
Non-Small Cell Lung Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P3
BB
(67)
Showing 3151 to 3175 of 18,135 assets
Previous
Page 127 of 726
Next